A Possible Cure For ME?
Myalgic encephalopathy/chronic exhaustion syndrome (MECS) is an extremely complex and disabling illness. Those with ME have physical limitations that are enhanced by sleep deprivation. Sometimes, ME/EMS can even limit a patient’s ability to perform their most basic activities such as getting dressed or eating. On the other hand, those with ME/CE may be completely capable of doing those things yet their symptoms are so severe that they can no longer do it.
Myalgic encephalopathy/chronic exhaustion syndrome (MECS) is an illness that is complicated, yet surprisingly common. It appears to be more widespread than many people think. It can also be a long-suspected, hidden illness masquerading as a number of diverse health problems.
ME/CE, also known as post-exertional syndrome, is a health condition in which patients have weak or reduced responses to stimulant-type drugs, possibly suggesting a lowered immune system. Some researchers think that ME is caused by an inflammation of the brain, but for now there is no conclusive evidence. The symptoms of this illness include muscular weakness, mental fatigue, muscle spasms, severe pain, neurological irregularities, and changes in blood pressure and temperature. In addition to these symptoms, ME sometimes causes gastrointestinal complaints such as nausea and vomiting, abdominal pain, diarrhea, constipation, or blood in the stool.
It is believed that the reduced immune system results in an adverse reaction in the brain and causes many symptoms of myalgic encephalomyelitis or chronic fatigue syndrome. Many people believe that ME is caused by several factors. These factors include: infectious agents, chemicals used in certain pharmaceuticals, parasites, allergies, stress, and toxins. However, researchers have found that the majority of cases are caused by a defect in the brain’s ability to properly process and communicate information from the nervous system to the rest of the body.
There is currently no cure for ME. However, many researchers have been successful in identifying and treating some of the symptoms. For example, medical professionals have identified and successfully treated a wide range of illnesses over the past two decades, including fibromyalgia, chronic fatigue syndrome, and multiple sclerosis. Doctors today generally treat ME with medications and therapies in order to alleviate the symptoms and prevent the development of more serious complications.
In recent years, biotechnology has made significant strides in ME research and development. One biotechnology firm, Novartis, has been focusing on developing vaccines that would provide a strong defense against myalgic encephalomyelitis and chronic fatigue syndrome, as well as other diseases and disorders. The ME vaccine being developed by this company is currently in phase II clinical trials. If it successfully passes the FDA testing stage, it will become a powerful weapon in the fight against ME. However, as with any new medical technology, more research and analysis is needed to determine if the vaccine can indeed provide an effective treatment for those with chronic fatigue syndrome and similar syndromes.